Collins, Menendez Introduce Bipartisan Bill to Ensure Diversity in NIH Clinical Trials
December 31, 2022
December 31, 2022
WASHINGTON, Dec. 31 -- Sen. Susan M. Collins, R-Maine, issued the following news release on Dec. 30, 2022:
U.S. Senators Susan Collins (R-ME) and Bob Menendez (D-NJ) today introduced bipartisan legislation to increase the diversity of participants in all National Institutes of Health (NIH)-funded trials. The NIH Clinical Trial Diversity Act builds upon the NIH's current policies to enhance the inclusion of women, racially and ethnically diverse individuals and people across the . . .
U.S. Senators Susan Collins (R-ME) and Bob Menendez (D-NJ) today introduced bipartisan legislation to increase the diversity of participants in all National Institutes of Health (NIH)-funded trials. The NIH Clinical Trial Diversity Act builds upon the NIH's current policies to enhance the inclusion of women, racially and ethnically diverse individuals and people across the . . .